| Professional
Info eNEWSLETTER Other Issues
|
JOIN THE DISCUSSION: NOW
AVAILABLE HERE! -
TOP ?? - PREVIOUS QUESTIONS AND REPLIES
- ?? QUESTION: "A woman has been on lithium for 10 years. Her mother states that she cannot be off it for more than 3 days, but her surgeon requests that she be off it for 2 weeks. What is the safe time frame to be off this medication before surgery?" -- From L.S., Louisiana REPLY:"While the surgeon should be commended for taking a conservative course, this may a case of "mother knows best". Although some authorities recommend discontinuing lithium for 2 weeks before ECT because it may interfere with the therapeutic effectiveness of the ECT, and increase the incidence and severity of memory loss, I am aware of no literature which supports discontinuing the drug before elective surgery. Indeed, for the patient with a severe manic-depressive disorder, maintaining the drug may be critical in preventing life-threatening actions potentially associated with relapse into a manic state.""Nevertheless, there are several considerations which one must be aware of when providing anesthesia to patients receiving lithium therapy: potential prolongation of neuromuscular blockade (established for succinylcholine and pancuronium; not studied for the newer agents); possible potentiation of the action of sedative/hypnotics (established for barbiturates and diazepam; not studied for propofol, midazolam, or other newer agents); potential cardiac arrhythmias and conduction abnormalities (documented in lithium toxicity; one case report of atropine-resistant bradycardia during anesthesia with propofol and fentanyl); and the possibility of hypothyroidism and nephrogenic diabetes insipidus precipitated by the lithium therapy.""In the case described above, I would suggest that these anesthetic considerations be discussed with the mother so that she is aware of the importance of the situation, and then the mother's opinion of the maximum duration her daughter can have the lithium discontinued before surgery should be followed. (Manic-depressive patients themselves are notoriously unreliable in assessing their own need for therapy and should not be relied upon to make this decision). "-- From D.D., Houston, TXIf you would like to add your own reply to the above question, please click here.
QUESTION:"I am being besieged by the morbidly obese with diagnosed or suspected sleep apnea. I am familiar with Dr. Benumof's ASA Refresher Course article and several letters to the editor. I am also aware that this subject will be discussed at the upcoming SAMBA meeting. I am having difficulty putting together a policy re: sleep apnea. Does anyone have anything that might help me?"-- From S.R., Dallas, TXREPLY 1: "Unfortunately there is very little data available which helps us develop evidence-based protocols for the management of OSA patients. The vast majority of published information is either retrospective reviews, case reports, or opinion. We do know that the number of patients with OSA is expected to increase 5-10 fold over the next decade so this problem is not going away. It is estimated that 4% of middle-aged males and 2% of females have OSA and 80-90% of patients have not been diagnosed." "Patients
with OSA are at increased risk for perioperative problems including
difficult intubation, postoperative hypoxia, hypercarbia, ischemia
and reintubation. There are 19 cases of patients with OSA in the ASA
closed claims database. In 18/19 cases, the patient sustained brain
damage or death related to adverse respiratory system events. There
is a recent report in the Anesthesia Patient Safety Foundation Newsletter
(Lofsky APSF Newsletter 2002;17:24-5) describing 8 cases of "unexplained"
postoperative cardiopulmonary arrests. All patients received parenteral
narcotics and were ultimately diagnosed with OSA." -- From Janet van Vlymen, MD, FRCPC, Kingston, Ontario, Canada REPLY 2: "Any discussion really
depends on the type of facility you practice in. I would not allow
surgery involving the airway in these patients if I worked in a free
standing unit. I feel that these patients should be admitted over-night
after general anesthesia and airway surgery. As you know they can
be difficult intubations. Most are not. But when these patients are
difficult intubations they can be very difficult. Our policy is to
approach these patients very cautiously. When in doubt, admit overnight.
Their recovery from general anesthesia is often stormy. Sitting them
up immediately after extubation helps. Expect lower oxygen saturations
early. They usually improve with time. These patients can die in the
postoperative period. They are especially sensitive to morphine."
"I am an anesthesiologist in New Orleans at an outpatient center. A surgeon in the group where I work is starting to do thyroid surgery there. This includes both subtotal and total thyroidectomies where the patient goes home the same day (not a 23 hr. stay). What are your views on outpatient thyroid surgery?" -- From D.M., New Orleans, LA
SAMBA MIDYEAR MEETING:
OCTOBER, 2003 -
TOP
The sixth annual event, focusing on the latest topics of importance to practitioners of ambulatory anesthesia, presented in the city that steals your heart away. General topics, presented by a faculty of leading experts, include:
Meeting programs are now available. (PDF file (2 MB)) Register online now!! The pre-registration deadline is September 19, 2003. Registrations received after that date will not be processed and will be returned so that the individuals can register on site.
SAMBA
ANNOUNCES $150,000 OUTCOMES RESEARCH AWARD -
TOP
AAAHC CREDENTIALING/PRIVILEGING
SEMINAR -
TOP
MEET THE
COMMITTEE: Subcommittee on Electronic Newsletter -
TOP
The Subcommittee members are:
2003 ANNUAL MEETING ABSTRACTS
-
TOP
DISTINGUISHED
SERVICE AWARD -
TOP FROM THE LITERATURE:
-
TOP
Purpose: The decision to cancel vascular access
surgery because of hyperkalemia requires knowledge of the risks vs
benefits. This study sought to identify and characterize cases where
surgery had been performed in patients with uncorrected hyperkalemia.
Purpose: To describe the clinical use of a new videolaryngoscope
in a patient who had repeatedly been difficult or impossible to intubate
by conventional direct laryngoscopy. This device provided excellent
glottic visualization and permitted easy endotracheal intubation.
Upper airway obstruction is common during both anaesthesia and sleep. Obstruction is caused by loss of muscle tone present in the awake state. The velopharynx, a particularly narrow segment, is especially predisposed to obstruction in both states. Patients with a tendency to upper airway obstruction during sleep are vulnerable during anaesthesia and sedation. Loss of wakefulness is compounded by depression of airway muscle activity by the agents, and depression of the ability to arouse, so they cannot respond adequately to asphyxia. Identifying the patient at risk is vital. Previous anaesthetic history and investigations of the upper airway are helpful, and a history of upper airway compromise during sleep (snoring, obstructive apnoeas) should be sought. Beyond these, risk identification is essentially a search for factors that narrow the airway. These include obesity, maxillary hypoplasia, mandibular retrusion, bulbar muscle weakness and specific obstructive lesions such as nasal obstruction or adenotonsillar hypertrophy. Such abnormalities not only increase vulnerability to upper airway obstruction during sleep or anaesthesia, but also make intubation difficult. While problems with airway maintenance may be obviated during anaesthesia by the use of aids such as the laryngeal mask airway (LMA ), identification of risk and caution are keys to management, and the airway should be secured before anaesthesia where doubt exists. If tracheal intubation is needed, spontaneous breathing until intubation is an important principle. Every anaesthetist should have in mind a plan for failed intubation or, worse, failed ventilation.
Obstruction of the upper airway occurs frequently in anesthetized,
spontaneously breathing children, especially in those with adenoidal
hyperplasia. To improve airway patency, maneuvers such as chin lift
(CL), jaw thrust (JT), and continuous positive airway pressure (CPAP)
are often used. In this study, we examined the comparative efficacy
of these maneuvers in children scheduled to undergo adenoidectomy.
Sixteen children aged 29 yr were anesthetized with sevoflurane.
During spontaneous breathing, the flows and pressures in the mask
(ma), oropharynx (op), and esophagus (es) were measured simultaneously,
and maximal pressure differences during inspiration (
IMPLICATIONS: We present evidence-based guidelines developed by an international panel of experts for the management of postoperative nausea and vomiting.
Cervical cerclage is often performed as an outpatient procedure under
subarachnoid anesthesia. Lidocaine was historically the drug of choice
for short procedures but has fallen out of favor because of concerns
of transient neurologic symptoms (TNS). We performed this study to
determine whether small-dose bupivacaine is an acceptable alternative
to lidocaine for cervical cerclage. We randomized 59 women to receive
either subarachnoid isobaric lidocaine 30 mg or hyperbaric bupivacaine
5.25 mg. Fentanyl 20 mcg was added to both local anesthetics, and
the total volume was diluted to 3 mL with 0.9% saline. Onset and highest
dermatomal level of sensory block; quality of anesthesia; hypotension;
and times until T12 regression, return of lower extremity motor function,
ambulation, and micturition were recorded. Symptoms of TNS were evaluated
by telephone interview 24 h after surgery. We did not find any significant
difference in onset or recovery times between the groups, with the
exception of a longer duration until return of lower extremity motor
strength in the lidocaine group. Symptoms consistent with TNS that
resolved spontaneously within 48 h were reported by two women in the
lidocaine group but by none in the bupivacaine group. We conclude
that subarachnoid bupivacaine offers a satisfactory alternative to
subarachnoid lidocaine for cervical cerclage.
Background: After induction of anesthesia, lung
resistance increases. The authors hypothesized that prophylactic bronchodilator
treatment with intravenous colforsin daropate, a water-soluble forskolin
derivative, before tracheal intubation would result in decreased lung
resistance and increased lung compliance after tracheal intubation
when compared with placebo medication. Narcotrend Monitoring Allows Faster Emergence and a Reduction
of Drug Consumption in Propofol-Remifentanil Anesthesia Background: The Narcotrend is a new electroencephalographic
monitor designed to measure depth of anesthesia, based on a six-letter
classification from A (awake) to F (increasing burst suppression)
including 14 substages. This study was designed to investigate the
impact of Narcotrend monitoring on recovery times and propofol consumption
in comparison to Bispectral Index® (BIS®) monitoring or standard
anesthetic practice.
CONTINUOUS three-in-one blockade is widely used for providing postoperative
analgesia after knee surgery. Distinct serious complications have
been described after femoral nerve block: neurologic injury as well
as hematoma compressive and epidural anesthesia. We report a case
of psoas abscess complicating a continuous three-in-one blockade.
Background: This study investigates whether long-term
treatment with an angiotensin converting enzyme inhibitor (ACEI) impairs
the hemodynamic regulation during the early phase of spinal anaesthesia.
Serious adverse reactions to ropivacaine and lidocaine are rare. In this report, we describe a case of sudden cardiac arrest after an interscalene brachial plexus block with a mixture of 150 mg of ropivacaine and 360 mg of lidocaine in a previously healthy, 34-year-old, 97-kg man. Severe hypotension occurred after successful resuscitation, necessitating an infusion of epinephrine. The patient developed pulmonary oedema, and was mechanically ventilated for 22 h. He eventually made a good recovery. We conclude that although ropivacaine and lidocaine are often considered relatively safe local anesthetics, serious cardiovascular complications can occur after the use of these drugs.
Introduction: Postoperative nausea and vomiting
remain a common problem following breast surgery. This study assesses
whether dexamethasone is as effective as ondansetron in the control
of postoperative nausea and vomiting (PONV). Background: The laryngeal tube has a potential role
during anaesthesia, but there have been only a few studies assessing
its efficacy during the entire course of anaesthesia, and all previous
studies used prototypes. We studied 100 patients to assess the efficacy
of a new laryngeal tube during the entire course of anaesthesia. PUB MED - TOP Adverse events with outpatient anesthesia in Massachusetts PURPOSE: This retrospective study documented the
frequency of various complications associated with outpatient anesthesia.
As the number and type of surgeries performed in the ambulatory setting have increased, outcomes research has allowed for better analysis of the safety and efficacy of care given to patients. Though this once involved measures of clinical morbidity and mortality alone, researchers have begun to focus their attention beyond these end points and take into account patients' postoperative functional status and satisfaction as a way to assess the overall quality of patient care. Also key in this move to a more global assessment of health care interventions has been an increased focus on economic outcomes. As new anesthetic drugs and techniques continue to develop, outcomes research will continue to evolve in new directions, providing further information for improvements in patient care.
Ambulatory surgery provides quality care that is cost-effective. The use of innovative surgical and anesthetic techniques will allow larger numbers of patients to take advantage of the benefits of undergoing an elective operation on an ambulatory basis. Anesthesiologists will be faced with more complex surgery, which will require careful selection and assessment of patients to ensure continuity of the excellent safety record of ambulatory anesthesia. Minor adverse events, such as pain and PONV, are still common. The occurrence of these minor adverse advents is now the major area of quality assessment and an area where improvement could be targeted. Fast tracking facilitates earlier discharge, but we must ensure this has benefit to the patient as speedy discharge may mask the true incidence of adverse minor symptoms. This can lead to patient dissatisfaction and a poor impression of ambulatory surgery.
This article summarizes current guidelines in pediatric ambulatory anesthesia and surgery. The reader is provided with our department's current outpatient guidelines at Children's Hospital of Philadelphia and the rationale behind them. Whenever possible, the differences in anesthetic management for the freestanding surgicenter will be discussed. Appropriate patient and procedure selection, preoperative assessment, intraoperative and postoperative considerations, and protocols for follow-up are discussed.
The growing importance of ambulatory surgery during the past decade has led to the development of efficient anesthetic techniques in terms of quality and safety of anesthesia and recovery. In these challenging objectives, intravenous techniques have played an important role, as they provide safe, efficient, and cost-effective anesthesia in the ambulatory setting. Among the numerous intravenous drugs, propofol, with its fast and smooth onset of action, short duration of action, and low incidence of postoperative side effects appears to be the anesthetic of choice in this situation. The recent development of new techniques of administration (such as TCI, monitored anesthesia care, or patient-controlled sedation) and monitoring (such as the BIS and the availability of "hit and run" drugs such as remifentanil) will optimize intraoperative conditions and recovery, thus allowing faster home readiness in the ambulatory setting.
In the current health care environment, anesthesia practitioners are frequently required to reevaluate their practice to be more efficient and cost-effective. Although IV induction with propofol and inhalational induction with sevoflurane are both suitable techniques for outpatients, patients prefer IV induction. Maintenance of anesthesia with the newer inhaled anesthetics (ie, desflurane and sevoflurane) provide for a rapid early recovery as compared with infusion of propofol (ie, TIVA), while allowing easy titratability of anesthetic depth. Titration of hypnotic sedatives using BIS monitoring may reduce the time to awakening and thereby may facilitate fast tracking (ie, bypassing the PACU) and reduce hospital stay. Inhalational anesthesia is associated with a higher incidence of PONV, but no differences have been demonstrated with respect to late recovery (eg, PACU stay and home readiness). Although clinical differences between desflurane and sevoflurane appear to be small, desflurane may be associated with faster emergence, particularly in elderly and morbidly obese patients. Balanced anesthesia with IV propofol induction and inhalation anesthesia with N2O for maintenance, and an LMA for airway management, may be an optimal technique for ambulatory surgery. Inhalational anesthesia may have an economic advantage over a TIVA technique.
It is difficult to predict the future but foolish to ignore the past. The history of ambulatory anesthesia is one of many trends and societal or economic forces that have provided the impetus for the growth of the specialty. By understanding the events of the past one can have a greater understanding of the present and some insight into the possible trends of the future. Financial and societal forces will continue to drive the growth of ambulatory anesthesia. New technology, surgical techniques, and progress in anesthesiology will be financed and supported by society so long as ambulatory surgery continues to decrease the costs of health care. Although new technology may increase the direct costs of providing care in the operating room, the overall costs to society should be reduced by a decrease in lost productivity and individual suffering on the part of the patients. Regardless of future changes, the anesthesiologist must remain dedicated to the safety and comfort of the patient first and foremost. If that happens, then the future of ambulatory anesthesiology and surgery will continue to be bright.
The management of PONV has improved significantly over the years but remains a frequent occurrence in postoperative patients. Evaluation of individual patient risk and the consideration for prophylactic antiemetic in high-risk populations should reduce these unpleasant symptoms and help direct appropriate clinical strategies. Treatment following failure of prophylactic antiemetic therapy requires knowledge of previously used antiemetics and the time of their administration.
The introduction of government-mandated standards for pain management has focused our attention on postoperative pain. With the recent JACHO standards' for ambulatory surgery, it is imperative that all health care workers who care for these patients are familiar with appropriate pain management. Developments in our understanding of the pathophysiology of acute pain have further enhanced our ability to improve pain management for postoperative ambulatory patients. This has led to the concept of preventive analgesia (inhibition of physiological and pathological secondary inflammatory pain). Extensive work has shown that this is best achieved using a multimodel approach usually consisting of an NSAID, opioid, and local anesthetic. NMDA antagonists (ketamine, dextromethorphan) and alpha-2 agnoists (clonodine) show potential supplements to further enhance pain management, especially if given preemptively. Nonpharmacological intervention such as cold therapy or acupuncture may also be considered. The armanentarium for effective pain management has improved substantially over the past few years. The challenge is for health care workers to implement these therapies to obtain optimum pain management in ambulatory surgical patients. NEWS FOR PATIENTS
-
TOP
To find out more, go to our web site and click on Sustaining
Sponsors on the bottom of our home page. THIS NEWSLETTER
IS AVAILABLE ON AVANTGO.COM -
TOP
|